Skip to main content
Addgene

Design of orthogonal genetic switches based on a crosstalk map of sigmas, anti-sigmas, and promoters.

Rhodius VA, Segall-Shapiro TH, Sharon BD, Ghodasara A, Orlova E, Tabakh H, Burkhardt DH, Clancy K, Peterson TC, Gross CA, Voigt CA
Mol Syst Biol. 2013 Oct 29;9:702. doi: 10.1038/msb.2013.58. (Link opens in a new window) PubMed (Link opens in a new window) Article

Using a combination of bioinformatics and functional assays, Christopher Voigt’s lab has identified a number of ECF σ factors, σ promoters, and anti-σ factors that are functional in E. coli. A subset of these elements act orthogonally to one another, and can be used to build orthogonal genetic switches.

This publication from the Voigt lab describes the identification, synthesis, and characterization of 86 ECF σ factors, their promoters, and 62 anti-σs. Fifty-two ECF σ factors were shown to be highly active in E. coli when paired with 24 promoters. Of these, a set of 20 orthogonal σ: promoter pairs was identified for use in building genetic programs. Similarly, 25 anti-σ factors were shown to strongly repress the activity of an active ECF σ factor, and a subset of 12 orthogonal pairs was identified.

Voigt Lab Repressors for Orthogonal Logic Gates

The Voigt lab has deposited 52 pVRa plasmids encoding active ECF σ factors, 24 pVRb plasmids encoding σ promoters, 25 pVRc plasmids encoding anti-σ factors, and an accessory plasmid that produces T7 RNA polymerase (pN565).

Plasmids from Article

ID Plasmid Purpose
49652pVRa01_3473
49653pVRa02_915
49654pVRa02_2817
49655pVRa03_1198
49656pVRa03_1244
49657pVRa04_1609
49658pVRa04_1617
49659pVRa07_980
49660pVRa07_1134
49661pVRa11_987
49662pVRa11_3726
49663pVRa12_807
49664pVRa12_808
49665pVRa14_1324
49666pVRa14_3200
49667pVRa15_436
49668pVRa15_524
49669pVRa16_973
49670pVRa16_3622
49671pVRa17_1458
49672pVRa17_1691
49673pVRa20_992
49674pVRa20_2913
49675pVRa22_1147
49676pVRa22_4450
49677pVRa25_1643
49678pVRa25_1645
49679pVRa26_837
49680pVRa26_4464
49681pVRa27_1331
49682pVRa27_4265
49683pVRa28_1088
49684pVRa29_371
49685pVRa30_35
49686pVRa30_83
49687pVRa31_34
49688pVRa31_2963
49689pVRa32_1122
49690pVRa32_3724
49691pVRa33_375
49692pVRa33_423
49693pVRa34_1384
49694pVRa34_3302
49695pVRa35_3582
49696pVRa37_2513
49697pVRa37_3390
49698pVRa38_1322
49699pVRa38_1442
49700pVRa39_2973
49701pVRa40_3198
49702pVRa41_491
49703pVRa42_4454
49704pVRb01_syn20
49705pVRb02_2817
49706pVRb03_up1198
49707pVRb11_3726
49708pVRb12_up807
49709pVRb15_up436
49710pVRb16_3622
49711pVRb17_up1691
49712pVRb18_up1700
49713pVRb19_up1315
49714pVRb20_992
49715pVRb21_up4014
49716pVRb22_up1147
49717pVRb25_up4311
49718pVRb26_up601
49719pVRb29_up371
49720pVRb30_2079
49721pVRb31_34
49722pVRb32_1122
49723pVRb33_375
49724pVRb38_up1322
49725pVRb39_up1413
49726pVRb41_up1141
49727pVRb42_up4062
49728pVRc01_3473
49729pVRc02_915
49730pVRc03_1198
49731pVRc03_1244
49732pVRc04_1609
49733pVRc11_987
49734pVRc14_1324
49735pVRc15_436
49736pVRc15_524
49737pVRc16_973
49738pVRc16_3622
49739pVRc20_992
49740pVRc22_1147
49741pVRc22_4450
49742pVRc25_1643_cl43
49743pVRc25_1645
49744pVRc27_1331
49745pVRc27_4265
49746pVRc30_35
49747pVRc31_34
49748pVRc33_375
49749pVRc33_423
49750pVRc35_3582
49751pVRc37_2513
49752pVRc38_1322
49990pN565expresses an attenuated T7 RNAP under an isopropyl β-d-1-thiogalactopyranoside (IPTG) inducible control

Antibodies from Article